PF-Atlas › Clinical Trials › NCT03846570
Formoterol-beclomethasone in Patients With Bronchiectasis: a Randomized Controlled Trial
Formoterol-beclomethasone · Phase 3
Registry ID
NCT03846570
Phase
Phase 3
Status
Terminated
Drug / intervention
Formoterol-beclomethasone
Sponsor
Erasmus Medical Center
Start
2019-01-29
Enrollment
34
Locations
3
About this trial
Randomized, double-blind, placebo-controlled study comparing formoterol-beclometason 12/200 mcg BID versus placebo to evaluate the clinical effect on coughing in patients with non-cystic fibrosis (non-CF) bronchiectasis, native to inhaled corticosteroid (ICS) therapy and no history of asthma or chronic obstructive pulmonary disease (COPD)
Explore related
Medical disclaimer. This page summarizes public trial data for NCT03846570 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.